There are currently 1 ongoing clinical trials involving Creutzfeldt Jakob Disease
Of the 1 trials,1 trials are in Phase I
Furthermore, 1 trials are in Phase I
The global pharmaceutical industry is steadily developing new drugs for Creutzfeldt Jakob Disease, a central nervous system condition.
University College London Hospitals NHS Foundation Trust: The leading ongoing Creutzfeldt Jakob Disease related clinical trial sponsor
University College London Hospitals NHS Foundation Trust is among the notable clinical trial sponsors involved in Creutzfeldt Jakob Disease. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward